Skip to main content
. 2021 Oct 8;11:20012. doi: 10.1038/s41598-021-99404-8

Figure 5.

Figure 5

Sagittal SPECT/CT images of radiolabelled GCPQ (10 mg/kg) at 30 min, 2 h 30 min and 24 h after nasal administration to male mice (ac), the nasal delivery device (Naltos device) that may be used to deliver the prophylactic GCPQ powder, permission from Alchemy Pharmatech Ltd. (d).